Common Contracts
8 similar Underwriting Agreement contracts by Eyenovia, Inc., Graymark Healthcare, Inc., UniTek Global Services, Inc., others
1,200,000 SHARES EYENOVIA, inc. COMMON STOCK UNDERWRITING AGREEMENTUnderwriting Agreement • December 21st, 2018 • Eyenovia, Inc. • Pharmaceutical preparations • New York
Eyenovia, Inc., a Delaware corporation (the “Company”) proposes, subject to the terms and conditions stated herein, to issue and sell to the Underwriters named in Schedule VI hereto (the “Underwriters”), for whom National Securities Corporation is acting as representative (the “Representative”), an aggregate of 1,200,000 authorized but unissued shares (the “Firm Shares”) and, at the election of the Underwriters, upon the terms and conditions stated herein, up to 180,000 additional shares (the “Additional Shares”) of Common Stock, $0.0001 par value per share (the “Common Stock”), of the Company (the Firm Shares and the Additional Shares that the Underwriters elect to purchase pursuant to Section 3 hereof being collectively called the “Securities”). The offering, issuance and sale of the Securities to the Underwriters is herein referred to as the “Offering”.
SHARES EYENOVIA, inc. COMMON STOCK UNDERWRITING AGREEMENTUnderwriting Agreement • December 12th, 2018 • Eyenovia, Inc. • Pharmaceutical preparations • New York
Eyenovia, Inc., a Delaware corporation (the “Company”) proposes, subject to the terms and conditions stated herein, to issue and sell to the Underwriters named in Schedule VI hereto (the “Underwriters”), for whom National Securities Corporation is acting as representative (the “Representative”), an aggregate of _________ authorized but unissued shares (the “Firm Shares”) and, at the election of the Underwriters, upon the terms and conditions stated herein, up to _________ additional shares (the “Additional Shares”) of Common Stock, $0.0001 par value per share (the “Common Stock”), of the Company (the Firm Shares and the Additional Shares that the Underwriters elect to purchase pursuant to Section 3 hereof being collectively called the “Securities”). The offering, issuance and sale of the Securities to the Underwriters is herein referred to as the “Offering”.
VOLITIONRX LIMITED 2,250,000 SHARES OF COMMON STOCK UNDERWRITING AGREEMENTUnderwriting Agreement • September 30th, 2016 • Volitionrx LTD • In vitro & in vivo diagnostic substances • New York
VolitionRx Limited, a Delaware corporation (the “Company”) proposes, subject to the terms and conditions stated herein, to issue and sell to the several Underwriters named in Schedule VI hereto (each, an “Underwriter” and collectively, the “Underwriters”), for whom National Securities Corporation is acting as representative (the “Representative”), an aggregate of 2,250,000 authorized but unissued shares (the “Firm Shares”) of its Common Stock, par value $0.001 per share (the “Common Stock”) and, at the election of the Underwriters, upon the terms and conditions stated herein, up to an additional 337,500 shares of Common Stock (the “Additional Shares” and together with the Firm Shares, the “Securities”).
PEDEVCO CORP. 3,250,000 SHARES OF COMMON STOCK UNDERWRITING AGREEMENTUnderwriting Agreement • December 10th, 2013 • Pedevco Corp • Oil & gas field exploration services • New York
PEDEVCO Corp., a Texas corporation (the “Company”) proposes, subject to the terms and conditions stated herein, to issue and sell to National Securities Corporation and each of the other Underwriters named in Schedule VII hereto, if any (each, an “Underwriter” and collectively, the “Underwriters”), an aggregate of 3,250,000 authorized but unissued shares (the “Firm Shares”) and, at the election of the Underwriters, up to 487,500 additional shares (the “Additional Shares”) of Common Stock, $0.001 par value per share (the “Common Stock”), of the Company (the Firm Shares and the Additional Shares that the Underwriters elect to purchase pursuant to Section 3 hereof being collectively called the “Securities”).
6,000,000 Shares and 6,000,000 Warrants GRAYMARK HEALTHCARE, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • June 15th, 2011 • Graymark Healthcare, Inc. • Services-specialty outpatient facilities, nec • New York
Graymark Healthcare, Inc., a Oklahoma corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to Roth Capital Partners, LLC (the “Underwriter”) an aggregate of (i) 6,000,000 authorized but unissued shares (the “Firm Shares”) of Common Stock, par value $0.0001 per share (the “Common Stock”), of the Company and (ii) warrants (the “Firm Warrants” to purchase up to 6,000,000 shares of Common Stock of the company (the “Firm Warrant Shares”). The Company has granted the Underwriter the option to purchase an aggregate of up to (i) 900,000 additional shares of Common Stock (the “Option Shares”) and/or (ii) warrants (the “Option Warrants”) to purchase up to 900,000 shares of Common Stock of the Company (the “Option Warrant Shares”) and together with the Firm Warrant Shares, the “Warrant Shares”) as may be necessary to cover over-allotments made in connection with the offering. The Firm Shares and Option Shares are collectively referred to as t
6,000,000 Shares and 6,000,000 Warrants GRAYMARK HEALTHCARE, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • June 9th, 2011 • Graymark Healthcare, Inc. • Services-specialty outpatient facilities, nec • New York
Graymark Healthcare, Inc., a Oklahoma corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to Roth Capital Partners, LLC (the “Underwriter”) an aggregate of (i) 6,000,000 authorized but unissued shares (the “Firm Shares”) of Common Stock, par value $0.0001 per share (the “Common Stock”), of the Company and (ii) warrants (the “Firm Warrants” to purchase up to 6,000,000 shares of Common Stock of the company (the “Firm Warrant Shares”). The Company has granted the Underwriter the option to purchase an aggregate of up to (i) 900,000 additional shares of Common Stock (the “Option Shares”) and/or (ii) warrants (the “Option Warrants”) to purchase up to 900,000 shares of Common Stock of the Company (the “Option Warrant Shares”) and together with the Firm Warrant Shares, the “Warrant Shares”) as may be necessary to cover over-allotments made in connection with the offering. The Firm Shares and Option Shares are collectively referred to as t
UNITEK GLOBAL SERVICES, INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • November 15th, 2010 • UniTek Global Services, Inc. • Radiotelephone communications • New York
UniTek Global Services, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the several underwriters listed in Schedule I hereto (the “Underwriters”), an aggregate of 19,000,000 authorized but unissued shares (the “Underwritten Shares”) of Common Stock, par value $0.00002 per share (the “Common Stock”), of the Company. The Company has granted the Underwriters the option to purchase an aggregate of up to 2,850,000 additional shares of Common Stock (the “Additional Shares”) solely as may be necessary to cover over-allotments made in connection with the offering. The Underwritten Shares and Additional Shares are collectively referred to as the “Shares.” FBR Capital Markets & Co. and Roth Capital Partners, LLC, have agreed to act as the representatives of the several Underwriters (in such capacity, the “Representatives”) in connection with the offering and sale of the Shares.
16,666,667 Shares UNITEK GLOBAL SERVICES, INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • October 28th, 2010 • UniTek Global Services, Inc. • Radiotelephone communications • New York
UniTek Global Services, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the several underwriters listed in Schedule I hereto (the “Underwriters”), an aggregate of 16,666,667 authorized but unissued shares (the “Underwritten Shares”) of Common Stock, par value $0.00002 per share (the “Common Stock”), of the Company. The Company has granted the Underwriters the option to purchase an aggregate of up to 2,500,000 additional shares of Common Stock (the “Additional Shares”) solely as may be necessary to cover over-allotments made in connection with the offering. The Underwritten Shares and Additional Shares are collectively referred to as the “Shares.” FBR Capital Markets & Co. and Roth Capital Partners, LLC, have agreed to act as the representatives of the several Underwriters (in such capacity, the “Representatives”) in connection with the offering and sale of the Shares.
